IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Reader Login
Users Online : 2513 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Ľ   My Preferences 
  Ľ   Manuscript submission


Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2021| May-June  | Volume 53 | Issue 3  
    Online since June 22, 2021

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak
Vidya Mahalmani, J Kumaravel, Manav Jain, Ajay Prakash, Bikash Medhi
May-June 2021, 53(3):187-191
DOI:10.4103/ijp.ijp_430_21  PMID:34169902
  3,100 201 -
Retrospective pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease
Vardhipathi Sravana Swathi, Shrishti Saroha, Jai Prakash, Shashi Bhushan
May-June 2021, 53(3):192-197
DOI:10.4103/ijp.IJP_704_20  PMID:34169903
  2,975 241 -
Nephroprotective effects of ethanolic root extract of Azima tetracantha lam in adenine-induced chronic kidney failure in Wistar rats
Ruckmani Arunachalam, Venu Gopala Rao Konda, Madhavi Eerike, Arun Kumar Radhakrishnan, Sobita Devi
May-June 2021, 53(3):198-206
DOI:10.4103/ijp.IJP_552_19  PMID:34169904
  2,584 200 -
Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review
Ajay Prakash, Sukhmeet Kaur, Charanjeet Kaur, Praisy K Prabha, Anusuya Bhatacharya, Phulen Sarma, Bikash Medhi
May-June 2021, 53(3):236-243
DOI:10.4103/ijp.ijp_382_21  PMID:34169911
  1,967 139 -
Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
Erkan Cure, Adem Kucuk, Medine Cumhur Cure
May-June 2021, 53(3):226-228
DOI:10.4103/ijp.IJP_615_20  PMID:34169908
  1,357 62 -
Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study
Anitha Gunalan, Dhandapani Sarumathi, Apurba Sankar Sastry, Venkateswaran Ramanathan, Sathish Rajaa, Sujatha Sistla
May-June 2021, 53(3):207-212
DOI:10.4103/ijp.ijp_1013_20  PMID:34169905
  1,317 84 -
The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study
Jithin Chacko, Shankar Dhandapani, Vidhya Jahagiridhar, Krishnan Swaminathan
May-June 2021, 53(3):229-233
DOI:10.4103/ijp.IJP_669_18  PMID:34169909
  1,260 77 -
Evaluation of vanillin as a probe drug for aldehyde oxidase and phenotyping for its activity in a Western Indian Cohort
Sandhya Subash, Nithya J Gogtay, Krishna R Iyer, Prajakta Gandhe, Ritu Budania, Urmila M Thatte
May-June 2021, 53(3):213-220
DOI:10.4103/ijp.IJP_463_18  PMID:34169906
  1,240 81 -
Copper-lowering agents as an adjuvant in chemotherapy
Pramod Kadu, Bhakti Sawant, Pravin Popatrao Kale, Kedar Prabhavalkar
May-June 2021, 53(3):221-225
DOI:10.4103/ijp.IJP_68_20  PMID:34169907
  1,200 58 -
A case report on azathioprine-induced euprolactinemic galactorrhea
Deepa Chaudhary, Ratinder Jhaj
May-June 2021, 53(3):234-235
DOI:10.4103/ijp.ijp_159_18  PMID:34169910
  1,145 59 -
Written informed consent to virtual e-consent in clinical research: Changing necessity during COVID times
Apoorva Mathur
May-June 2021, 53(3):248-249
DOI:10.4103/ijp.ijp_331_21  PMID:34169914
  905 69 -
Attitude toward COVID-19 vaccination: A cross-sectional study on healthcare professionals
Suresh Velumani, Patel Arpita, Ramachandran Balaraman
May-June 2021, 53(3):250-251
DOI:10.4103/ijp.ijp_173_21  PMID:34169915
  826 90 -
Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19
Yethindra Vityala, Tugolbai Tagaev, Sagynali Mamatov, Ziiabidin Aidarov, Panchadcharam Harinath
May-June 2021, 53(3):246-247
DOI:10.4103/ijp.IJP_33_21  PMID:34169913
  685 51 -
Candidiasis in patients treated with interleukin-17 inhibitors
Nerea BŠez-Gutierrez, Hťctor RodrŪguez-Ramallo
May-June 2021, 53(3):244-245
DOI:10.4103/ijp.ijp_1178_20  PMID:34169912
  332 15 -
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow